NPR2

NPR2 Full Name

natriuretic peptide receptor 2

NPR2 Introduction

NPR2 (natriuretic peptide receptor 2), also known as guanylate cyclase-B (GC-B), is a key membrane receptor that translates extracellular growth signals into intracellular cGMP production. For individuals facing unexplained short stature or suspected skeletal dysplasia, NPR2 represents one of the most clinically relevant yet often overlooked genetic determinants of bone growth. When activated by C-type natriuretic peptide (CNP), NPR2 triggers guanylate cyclase activity, elevating cGMP levels and regulating downstream pathways that control chondrocyte proliferation, maturation, and endochondral ossification. Disruption of this signaling axis can subtly but profoundly impair growth plate function, leading to impaired longitudinal bone growth and a broad spectrum of skeletal development abnormalities that are frequently difficult to diagnose early in clinical practice.

From a functional perspective, NPR2 is highly expressed in growth plate chondrocytes, where it serves as a central regulator of skeletal elongation, but it is also present in multiple tissues including the cardiovascular system, brain, and reproductive organs. Structurally, the receptor contains several essential domains, including an extracellular ligand-binding region, a transmembrane segment, a kinase homology domain, and an intracellular guanylate cyclase catalytic domain. These domains work in coordination to ensure proper receptor activation and cGMP synthesis. Even subtle genetic alterations can disrupt protein stability, reduce membrane expression, or impair ligand-induced signaling. Recent mechanistic insights further suggest that NPR2 dysfunction may also involve cellular stress responses such as endoplasmic reticulum stress, adding another layer of complexity to how receptor impairment translates into defective chondrocyte differentiation and altered growth signaling networks.

Clinically, NPR2 is increasingly recognized as a dosage-sensitive growth regulator, where both loss-of-function and gain-of-function variants can lead to striking but opposite phenotypes. Reduced NPR2 activity is strongly associated with autosomal dominant short stature and various forms of skeletal dysplasia due to insufficient cGMP signaling in the growth plate, while activating mutations can result in excessive skeletal growth and unusually tall stature without major deformities. These contrasting outcomes highlight the finely balanced role of NPR2 in human height determination. Beyond genetic findings, the broader NPR2 signaling pathway has also become a therapeutic focus, as modulation of CNP–NPR2 signaling is now being explored as a strategy to correct growth plate dysfunction and treat pediatric growth disorders, offering a promising direction for conditions that currently lack effective long-term interventions.

Alternate Names for NPR2

NPR2; natriuretic peptide receptor 2; AMDM; ANPb; NPRB; ANPRB; GUC2B; NPRBi; GUCY2B; atrial natriuretic peptide receptor 2

• 1.Li Q, et al.; Novel NPR2 Gene Mutations Affect Chondrocytes Function via ER Stress in Short Stature. Cells. 2022 Apr 8;11(8):1265.
  2.Hannema SE, et al.; An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. J Clin Endocrinol Metab. 2013 Dec;98(12):E1988-98.